DAMARTEX (ALDAR.PA) Fundamental Analysis & Valuation

EPA:ALDAR • FR0000185423

Current stock price

2.4 EUR
0 (0%)
Last:

This ALDAR.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALDAR.PA Profitability Analysis

1.1 Basic Checks

  • ALDAR had negative earnings in the past year.
  • In the past year ALDAR had a positive cash flow from operations.
  • In the past 5 years ALDAR reported 4 times negative net income.
  • Of the past 5 years ALDAR 4 years had a positive operating cash flow.
ALDAR.PA Yearly Net Income VS EBIT VS OCF VS FCFALDAR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.17%, ALDAR is doing worse than 79.07% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -24.97%, ALDAR is doing worse than 81.40% of the companies in the same industry.
Industry RankSector Rank
ROA -4.17%
ROE -24.97%
ROIC N/A
ROA(3y)-6.1%
ROA(5y)-3.23%
ROE(3y)-30.63%
ROE(5y)-17.05%
ROIC(3y)N/A
ROIC(5y)N/A
ALDAR.PA Yearly ROA, ROE, ROICALDAR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • ALDAR's Gross Margin of 64.90% is in line compared to the rest of the industry. ALDAR outperforms 51.16% of its industry peers.
  • ALDAR's Gross Margin has been stable in the last couple of years.
  • ALDAR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y-0.01%
ALDAR.PA Yearly Profit, Operating, Gross MarginsALDAR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1

2. ALDAR.PA Health Analysis

2.1 Basic Checks

  • ALDAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALDAR has about the same amount of shares outstanding.
  • ALDAR has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALDAR has a worse debt to assets ratio.
ALDAR.PA Yearly Shares OutstandingALDAR.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
ALDAR.PA Yearly Total Debt VS Total AssetsALDAR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • ALDAR has an Altman-Z score of 1.08. This is a bad value and indicates that ALDAR is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.08, ALDAR is doing worse than 62.79% of the companies in the same industry.
  • ALDAR has a debt to FCF ratio of 10.83. This is a negative value and a sign of low solvency as ALDAR would need 10.83 years to pay back of all of its debts.
  • ALDAR has a Debt to FCF ratio of 10.83. This is in the lower half of the industry: ALDAR underperforms 62.79% of its industry peers.
  • ALDAR has a Debt/Equity ratio of 2.67. This is a high value indicating a heavy dependency on external financing.
  • ALDAR's Debt to Equity ratio of 2.67 is on the low side compared to the rest of the industry. ALDAR is outperformed by 86.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF 10.83
Altman-Z 1.08
ROIC/WACCN/A
WACC4.75%
ALDAR.PA Yearly LT Debt VS Equity VS FCFALDAR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • ALDAR has a Current Ratio of 1.10. This is a normal value and indicates that ALDAR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.10, ALDAR is doing worse than 81.40% of the companies in the same industry.
  • ALDAR has a Quick Ratio of 1.10. This is a bad value and indicates that ALDAR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ALDAR (0.48) is worse than 81.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.48
ALDAR.PA Yearly Current Assets VS Current LiabilitesALDAR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

1

3. ALDAR.PA Growth Analysis

3.1 Past

  • ALDAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.84%, which is quite impressive.
  • The Revenue has decreased by -1.00% in the past year.
  • The Revenue has been decreasing by -5.35% on average over the past years.
EPS 1Y (TTM)49.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.14%
Revenue 1Y (TTM)-1%
Revenue growth 3Y-10.17%
Revenue growth 5Y-5.35%
Sales Q2Q%0.17%

3.2 Future

  • ALDAR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 444.33% yearly.
  • ALDAR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.58% yearly.
EPS Next Y-1433.33%
EPS Next 2Y444.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y-16.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALDAR.PA Yearly Revenue VS EstimatesALDAR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 200M 400M 600M
ALDAR.PA Yearly EPS VS EstimatesALDAR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

3

4. ALDAR.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALDAR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALDAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALDAR.PA Price Earnings VS Forward Price EarningsALDAR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALDAR indicates a somewhat cheap valuation: ALDAR is cheaper than 76.74% of the companies listed in the same industry.
  • 100.00% of the companies in the same industry are more expensive than ALDAR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.4
EV/EBITDA 7.32
ALDAR.PA Per share dataALDAR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALDAR's earnings are expected to grow with 444.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y444.33%
EPS Next 3YN/A

0

5. ALDAR.PA Dividend Analysis

5.1 Amount

  • No dividends for ALDAR!.
Industry RankSector Rank
Dividend Yield 0%

ALDAR.PA Fundamentals: All Metrics, Ratios and Statistics

DAMARTEX

EPA:ALDAR (3/30/2026, 7:00:00 PM)

2.4

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-09
Earnings (Next)N/A
Inst Owners4.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.84M
Revenue(TTM)521.23M
Net Income(TTM)-17.60M
Analysts40
Price Target4.59 (91.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-217.65%
EPS NY rev (3m)-217.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 1.4
P/OCF 0.91
P/B 0.39
P/tB N/A
EV/EBITDA 7.32
EPS(TTM)-1.56
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)1.71
FCFY71.3%
OCF(TTM)2.64
OCFY110.06%
SpS44.93
BVpS6.08
TBVpS-4.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.17%
ROE -24.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.9%
FCFM 3.81%
ROA(3y)-6.1%
ROA(5y)-3.23%
ROE(3y)-30.63%
ROE(5y)-17.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y-0.01%
F-Score7
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF 10.83
Debt/EBITDA 6.19
Cap/Depr 33.26%
Cap/Sales 2.07%
Interest Coverage N/A
Cash Conversion 100.58%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.48
Altman-Z 1.08
F-Score7
WACC4.75%
ROIC/WACCN/A
Cap/Depr(3y)28.96%
Cap/Depr(5y)40.82%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.14%
EPS Next Y-1433.33%
EPS Next 2Y444.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1%
Revenue growth 3Y-10.17%
Revenue growth 5Y-5.35%
Sales Q2Q%0.17%
Revenue Next YearN/A
Revenue Next 2Y-16.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y92.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.55%
FCF growth 3YN/A
FCF growth 5Y1.01%
OCF growth 1Y-7.66%
OCF growth 3YN/A
OCF growth 5Y-0.56%

DAMARTEX / ALDAR.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DAMARTEX (ALDAR.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALDAR.PA.


What is the valuation status of DAMARTEX (ALDAR.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to DAMARTEX (ALDAR.PA). This can be considered as Overvalued.


How profitable is DAMARTEX (ALDAR.PA) stock?

DAMARTEX (ALDAR.PA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for DAMARTEX?

The Earnings per Share (EPS) of DAMARTEX (ALDAR.PA) is expected to decline by -1433.33% in the next year.